 BEIJING, May 20, 2021 GLOBE NEWSWIRE -- Genetron Holdings Limited Genetron Health or the Company, Nasdaq: GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced a strategic partnership with JD Health, a subsidiary of JD.com, Inc., and the largest online healthcare platform in China. The two companies aim to create innovative solutions for full-cycle cancer management. 